within Pharmacolibrary.Drugs.ATC.J;

model J01DD04_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.3333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0056,
    k12             = 0.62,
    k21             = 0.62
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DD04_1</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ceftriaxone is a third-generation cephalosporin antibiotic with broad-spectrum activity against both gram-positive and gram-negative bacteria. It is widely used for the treatment of infections such as pneumonia, meningitis, gonorrhea, and sepsis. Ceftriaxone is approved for clinical use worldwide and is often administered intravenously or intramuscularly in both hospital and outpatient settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects after single intramuscular administration.</p><h4>References</h4><ol><li><p>Richards, DM, et al., &amp; Avery, GS (1984). Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. <i>Drugs</i> 27(6) 469–527. DOI:<a href=\"https://doi.org/10.2165/00003495-198427060-00001\">10.2165/00003495-198427060-00001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6329638/\">https://pubmed.ncbi.nlm.nih.gov/6329638</a></p></li><li><p>Holazo, AA, et al., &amp; Parsonnet, M (1986). Ceftriaxone pharmacokinetics following multiple intramuscular dosing. <i>European journal of clinical pharmacology</i> 30(1) 109–112. DOI:<a href=\"https://doi.org/10.1007/BF00614206\">10.1007/BF00614206</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3709623/\">https://pubmed.ncbi.nlm.nih.gov/3709623</a></p></li><li><p>Yuk, JH, et al., &amp; Quintiliani, R (1989). Clinical pharmacokinetics of ceftriaxone. <i>Clinical pharmacokinetics</i> 17(4) 223–235. DOI:<a href=\"https://doi.org/10.2165/00003088-198917040-00002\">10.2165/00003088-198917040-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2686882/\">https://pubmed.ncbi.nlm.nih.gov/2686882</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DD04_1;
